Sorafenib
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT (NCT04709380) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2021-03-02 |
| TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC (NCT04518852) | Sichuan Cancer Hospital and Research Institute | 2020-09-14 |
| TACE Plus Sorafenib Versus TACE Alone for Recurrent Intermediate Hepatocellular Carcinoma (NCT04103398) | Sun Yat-sen University | 2019-10-02 |
| Combined Treatment of RFA and Sorafenib on Recurrent HCC (NCT01470495) | Southwest Hospital, China | 2015-01-01 |
Track Sorafenib automatically
Every clearance here is in the API, with alerts when new ones post.